Home China Biologic Products Holdings, Inc.
C

China Biologic Products Holdings, Inc.

Profile managed by Bizz Id
China 2002

Description

China Biologic Products Holdings, known in China as Taibang Biological Group (泰邦生物集团), is one of the country's leading plasma-derived medicine manufacturers. Founded in 2002, it traded on Nasdaq under CBPO from 2009 until it was taken private in April 2021. Its subsidiary Guizhou Taibang, wholly owned since 2016, supplies a large share of the group's fractionation capacity. The catalogue combines finished plasma products — human albumin, intravenous immunoglobulin, hyperimmune immunoglobulins, factor VIII, prothrombin complex and fibrinogen — with a line of products and devices for collection and processing. It operates three sites: the Tai'an (Shandong) and Guiyang (Guizhou) fractionation bases, and the Tianxinfu device plant in Beijing.

Products

27 products
Absorbable Oral Repair Membrane

Medical device in clinical development per the company R&D page

Under development

Equipment or machinery

Verified on 2026-10-17

Artificial Dura Mater

Implantable medical device for repair and reconstruction of damaged or missing dura mater

Tech pack available

Equipment or machinery

Verified on 2026-10-17

Artificial Nerve Conduit

Collagen device for peripheral nerve repair and protection, bridging gaps up to 15 mm

Tech pack available

Equipment or machinery

Verified on 2026-10-17

Artificial Spinal Dura Mater

Implantable medical device; indication not published on the site

Tech pack available

Equipment or machinery

Verified on 2026-10-17

Biological Ocular Membrane

Medical device in clinical development per the company R&D page

Under development

Equipment or machinery

Verified on 2026-10-17

Human Albumin

Plasma-derived albumin for hypovolaemic shock, hypoalbuminaemia, oedema and ascites; 2 g, 5 g, 10 g and 12,5 g vials

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Albumin: see suppliers →

Human Antithrombin III

Plasma-derived product in clinical development per the company R&D page

Under development

Finished product (FDF)

Verified on 2026-10-17

Antithrombin III: see suppliers →

Human Coagulation Factor IX

Bleeding in patients with factor IX deficiency (haemophilia B); 500 IU / 10 ml vial

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Factor IX: see suppliers →

Human Coagulation Factor VIII

Haemophilia A and acquired factor VIII deficiency with bleeding; 200 IU and 300 IU vials, 10 ml reconstituted

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Factor VIII: see suppliers →

Human Cytomegalovirus Immunoglobulin

Plasma-derived product in clinical development per the company R&D page

Under development

Finished product (FDF)

Verified on 2026-10-17

Cytomegalovirus Immunoglobulin: see suppliers →

Human Fibrin Sealant

Plasma-derived product in clinical development per the company R&D page

Under development

Finished product (FDF)

Verified on 2026-10-17

Fibrin Sealant: see suppliers →

Human Fibrinogen

For coagulation disorders from congenital or acquired fibrinogen deficiency; 0,5 g vial, 25 ml reconstituted

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Fibrinogen: see suppliers →

Human Hepatitis B Immunoglobulin

Hepatitis B prophylaxis in newborns of HBsAg-positive mothers, accidental exposure and close contacts; 100, 200 and 400 IU vials

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Hepatitis B Immunoglobulin: see suppliers →

Human Immunoglobulin (pH4) for Intravenous Injection 10%

Intravenous immunoglobulin for primary and secondary IgG deficiency, ITP and Kawasaki disease; 5 g vial (10%, 50 ml)

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Immunoglobulin: see suppliers →

Human Immunoglobulin (pH4) for Intravenous Injection 5%

Intravenous immunoglobulin for immunoglobulin deficiency and autoimmune disease (ITP, Kawasaki); 1,25 g, 2,5 g and 5 g vials

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Immunoglobulin: see suppliers →

Human Immunoglobulin for Intramuscular Injection

Prevention of measles and infectious hepatitis; adjunct in severe infections; 150 mg and 300 mg vials

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Immunoglobulin: see suppliers →

Human Immunoglobulin for Intravenous Injection (caprylate/chromatography purified; 20 nm virus filtration)

Intravenous immunoglobulin purified by caprylate and chromatography with virus filtration; in clinical development

Under development

Finished product (FDF)

Verified on 2026-10-17

Immunoglobulin: see suppliers →

Human Prothrombin Complex

Congenital or acquired deficiency of factors II, VII, IX and X; bleeding from coumarin anticoagulants; 300 IU vial

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Prothrombin Complex: see suppliers →

Human Rabies Immunoglobulin

Passive immunisation after bite or scratch by a rabid animal; 100, 200 and 500 IU vials

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Rabies Immunoglobulin: see suppliers →

Human Tetanus Immunoglobulin

Tetanus prophylaxis and treatment, notably in patients allergic to tetanus antitoxin; 250 IU / 2,5 ml vial

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Tetanus Immunoglobulin: see suppliers →

Human von Willebrand Factor

Plasma-derived product in clinical development per the company R&D page

Under development

Finished product (FDF)

Verified on 2026-10-17

Von Willebrand Factor: see suppliers →

Multilayer Suture-free Artificial Dura Mater

Implantable medical device for repair and reconstruction of damaged or missing dura mater

Tech pack available

Equipment or machinery

Verified on 2026-10-17

Oral Biological Membrane

Medical device in clinical development per the company R&D page

Under development

Equipment or machinery

Verified on 2026-10-17

Placental Polypeptide Injection

Placental polypeptide injection; brand 如初然 (RETRUEGEN); indication not published

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Placental Polypeptide: see suppliers →

Second-generation Biological Dura Membrane

Medical device at registration stage per the company R&D page

Under development

Equipment or machinery

Verified on 2026-10-17

Single-use Tissue Expander

Single-use medical device; indication not published on the site

Tech pack available

Equipment or machinery

Verified on 2026-10-17

Tendon Membrane

Anti-adhesion degradable medical device for tendon repair and adhesion prevention

Tech pack available

Equipment or machinery

Verified on 2026-10-17

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free

Other locations

Taibang Shandong base
山东省泰安市高新区龙泉路5666号, Tai'an (China)
Taibang Guizhou base
贵州省贵阳市花溪区大黔路156号, Guiyang (China)
Taibang Tianxinfu device base
北京市昌平区科技园区火炬街30号, Beijing (China)